A pseudoautosomal glycosylation disorder prompts the revision of dolichol biosynthesis

Archive ouverte

Wilson, Matthew P. | Kentache, Takfarinas | Althoff, Charlotte | Schulz, Celine | de Bettignies, Geoffroy | Mateu Cabrera, Gisèle | Cimbalistiene, Loreta | Burnyte, Birute | Yoon, Grace | Costain, Gregory | Vuillaumier-Barrot, Sandrine | Cheillan, David | Rymen, Daisy | Rychtarova, Lucie | Hansikova, Hana | Bury, Marina | Dewulf, Joseph P. | Caligiore, Francesco | Jaeken, Jaak | Cantagrel, Vincent | van Schaftingen, Emile | Matthijs, Gert | Foulquier, Francois | Bommer, Guido T.

Edité par CCSD ; Elsevier -

International audience. Dolichol is a lipid critical for N-glycosylation as a carrier for activated sugars and nascent oligosaccharides. It is commonly thought to be directly produced from polyprenol by the enzyme SRD5A3. Instead, we found that dolichol synthesis requires a three-step detour involving additional metabolites, where SRD5A3 catalyzes only the second reaction. The first and third steps are performed by DHRSX, whose gene resides on the pseudoautosomal regions of the X and Y chromosomes. Accordingly, we report a pseudoautosomal-recessive disease presenting as a congenital disorder of glycosylation in patients with missense variants in DHRSX (DHRSX-CDG). Of note, DHRSX has a unique dual substrate and cofactor specificity, allowing it to act as a NAD+-dependent dehydrogenase and as a NADPH-dependent reductase in two non-consecutive steps. Thus, our work reveals unexpected complexity in the terminal steps of dolichol biosynthesis. Furthermore, we provide insights into the mechanism by which dolichol metabolism defects contribute to disease.

Suggestions

Du même auteur

A pseudoautosomal glycosylation disorder prompts the revision of dolichol biosynthesis

Archive ouverte | Wilson, Matthew, P | CCSD

International audience. Highlights d DHRSX deficiency leads to defective N-glycosylation by disrupting dolichol synthesis d DHRSX acts both as a reductase and a dehydrogenase in dolichol synthesis d Dolichol synthes...

SLC37A4‐CDG : Second patient

Archive ouverte | Wilson, Matthew P. | CCSD

International audience. Recently, a disorder caused by the heterozygous de novo c.1267C>T (p.R423*) substitution in SLC37A4 has been described. This causes mislocalization of the glucose-6-phosphate transporter to t...

CAMLG-CDG: a novel congenital disorder of glycosylation linked to defective membrane trafficking

Archive ouverte | Wilson, Matthew P | CCSD

International audience. The transmembrane domain recognition complex (TRC) pathway is required for the insertion of C-terminal tail-anchored (TA) proteins into the lipid bilayer of specific intracellular organelles ...

Chargement des enrichissements...